Odonate Therapeutics initiates Phase 3 trial for tesetaxel [Seeking Alpha]
Odonate Therapeutics, Inc. (ODT)
Last odonate therapeutics, inc. earnings: 4/28 08:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.odonate.com/contact-ir
Company Research
Source: Seeking Alpha
Odonate Therapeutics initiates Phase 3 trial for tesetaxelOdonate Therapeutics (Pending:ODT)initiates the Phase 3 CONTESSA trial of tesetaxel in patients with locally advanced or metastatic breast cancer.The trial’s primary endpoint is progression-free survival with secondary efficacy endpoints of overall survival, objective response rate, disease control rate, and patient-reported outcomes.Odonate shares aredown 1.8% premarket.See all stocks on the move »Now read:Disrupting Breast Cancer Paradigms - Odonate Therapeutics »
Show less
Read more
Impact Snapshot
Event Time:
ODT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ODT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ODT alerts
High impacting Odonate Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics